Phase II Study Comparing LR-GEM to R-GEM-P in Second-line Treatment of Diffuse Large B-cell Lymphoma (LEGEND)
Condition(s):Diffuse Large B-Cell LymphomaLast Updated:September 19, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Diffuse Large B-Cell LymphomaLast Updated:September 19, 2019Unknown status
Condition(s):Chemotherapy; Diffuse Large B-Cell Lymphoma (DLBCL), Nos; ElderlyLast Updated:February 8, 2023Recruiting
Condition(s):Diffuse Large B Cell LymphomaLast Updated:November 13, 2023Active, not recruiting
Condition(s):Diffuse Large B-cell LymphomaLast Updated:January 10, 2020Completed
Condition(s):Diffuse Large B-cell Lymphoma (DLBCL)Last Updated:March 18, 2024Recruiting
Condition(s):Diffuse Large B-Cell LymphomaLast Updated:October 19, 2023Completed
Condition(s):Diffuse Large B Cell LymphomaLast Updated:January 3, 2019Unknown status
Condition(s):Diffuse Large B-cell LymphomaLast Updated:August 18, 2023Not yet recruiting
Condition(s):Recurrent Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-cell LymphomaLast Updated:September 21, 2023Recruiting
Condition(s):Lymphoma, Large B-Cell, Diffuse; Gene Expression ProfilingLast Updated:April 8, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.